Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 7/2018

01-07-2018 | Literatur kommentiert

Verlängerung des rezidivfreien und Gesamtüberlebens beim Ovarialkarzinom im Stadium III durch hypertherme intraperitoneale Chemotherapie (HIPEC)

Author: Prof. Dr. med. Gerhard G. Grabenbauer

Published in: Strahlentherapie und Onkologie | Issue 7/2018

Login to get access

Auszug

Die Primärbehandlung des fortgeschrittenen Ovarialkarzinoms besteht aus der maximal zytoreduktiven Operation, gefolgt von einer systemischen Chemotherapie. Die hier kommentierte Studie [1] untersuchte den Wert einer hyperthermen intraperitonealen Chemotherapie (HIPEC) nach neoadjuvanter systemischer Polychemotherapie und Operation des Ovarialkarzinoms im Stadium III. …
Literature
1.
van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230–240CrossRefPubMed
2.
Mi D‑H, Li Z, Yang K‑H, Cao N, Lethaby A, Tian J‑H (2013) Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia 29(2):156–167CrossRefPubMed
3.
Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, Parisi A, Woo Y (2017) The 30-year experience—a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 79:1–14CrossRefPubMedPubMedCentral
4.
Huang C‑Q, Min Y, Wang S‑Y, Yang X‑J, Liu Y, Xiong B, Yonemura Y, Li Y (2017) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectalcancer: a systematic review and meta-analysis of current evidence. Oncotarget 8:55657–55683PubMedPubMedCentral
Metadata
Title
Verlängerung des rezidivfreien und Gesamtüberlebens beim Ovarialkarzinom im Stadium III durch hypertherme intraperitoneale Chemotherapie (HIPEC)
Author
Prof. Dr. med. Gerhard G. Grabenbauer
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 7/2018
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1311-5

Other articles of this Issue 7/2018

Strahlentherapie und Onkologie 7/2018 Go to the issue

Original Article

Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT

Original Article

The impact of [68Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancer

Literatur kommentiert

Abschätzung von Langzeitrisiken der modernen Strahlentherapie bei Patientinnen mit Mammakarzinom: Evidenz zu Strahlendosen an Lunge und Herz

Original Article

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Original Article

Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy

Original Article

Nonmetastatic pancreatic cancer